Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
A Review of Emerging Technologies in Diabetes Management for Multiple-Dose Insulin-Injecting Patients With Type 2 Diabetes Who Self-monitor Blood GlucoseMalgorzata Slugocki, Damian Bialonczyk, Ayşe Elif ÖzdenerThe Annals of Pharmacotherapy|December 22, 2020
Oral Superabsorbent Hydrogel (Plenity) for Weight ManagementAlexa Pass, Damian Bialonczyk, Elaine Chiquette, et al.Diabetes Technology & Therapeutics|December 25, 2015
Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative StudiesMichael Gibney, Zhenyi Xue, Monica Swinney, et al.JMIR Formative Research|January 5, 2023
Characteristics and Weight Loss Practices From a Cohort of 20,000 Patients Using Direct-to-Consumer Telehealth: Observational Cross-sectional StudyDeborah Bade Horn, Elizabeth Pash, Megan S Zhou, et al.Diabetic Medicine : a Journal of the British Diabetic Association|February 14, 2023
Person-first language in diabetes and obesity scientific publicationsJane K Dickinson, Damian Bialonczyk, Jessica Reece, et al.Diabetes, Obesity & Metabolism|August 5, 2025
Efficacy and safety of CT-868, a novel, fully biased, dual glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist, in type 2 diabetes: A double-blind, randomized placebo controlled phase 2 trialManu V Chakravarthy, Michael A Elliott, Luis Acosta, et al.Cell Reports. Medicine|June 3, 2025
Biased agonism of GLP-1R and GIPR enhances glucose lowering and weight loss, with dual GLP-1R/GIPR biased agonism yielding greater efficacyRuben Rodriguez, Anne Hergarden, Shyam Krishnan, et al.Molecular Metabolism|November 30, 2025
Effects of CT-388, a once-weekly signaling-biased dual GLP-1/GIP receptor agonist, on weight loss and glycemic control in preclinical models and participants with obesityManu V Chakravarthy, Ruben Rodriguez, Anne Hergarden, et al.Pageof 1